Analystreport

LogicBio Therapeutics, Inc. (NASDAQ: LOGC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

ContextLogic Inc. - Class A  (LOGC) 
Last contextlogic inc. - class a earnings: 8/13 08:00 am Check Earnings Report